BRUTON'S TYROSINE KINASE INHIBITION TO SUPPRESS MAST CELL ACTIVATION IN ATHEROSCLEROSIS

被引：0
|
作者：
Hemme, E. [1 ]
Delfos, L. [1 ]
Depuydt, M. A. C. [1 ]
Kleijn, M. N. A. Bernabe [1 ]
Schaftenaar, F. H. [1 ]
Foks, A. C. [1 ]
Kuiper, J. [1 ]
Bot, I. [1 ]
机构：
[1] Leiden Univ, Biotherapeut, LACDR, Leiden, Netherlands
来源：
ATHEROSCLEROSIS | 2022年 / 355卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP050
引用
收藏
页码：E100 / E100
页数：1
相关论文
共 50 条
  • [41] A phase II study of Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis
    Suresh, Ragha, V
    Dunnam, Collin
    Vaidya, Dhananjay
    Wood, Robert A.
    Bochner, Bruce S.
    MacGlashan Jr, Donald W.
    Dispenza, Melanie C.
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (16):
  • [42] Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease
    Stefan F. H. Neys
    Jasper Rip
    Rudi W. Hendriks
    Odilia B. J. Corneth
    Drugs, 2021, 81 : 1605 - 1626
  • [43] Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Models and Multiple Sclerosis
    Steinmaurer, Anja
    Wimmer, Isabella
    Berger, Thomas
    Rommer, Paulus S.
    Sellner, Johann
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (06) : 437 - 444
  • [44] Bruton's Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease
    Neys, Stefan F. H.
    Rip, Jasper
    Hendriks, Rudi W.
    Corneth, Odilia B. J.
    DRUGS, 2021, 81 (14) : 1605 - 1626
  • [45] A Bruton's Tyrosine Kinase Inhibitor Prevents Antigen-Driven B Cell Activation In Vivo
    Benson, Micah
    Rodriguez, Varenka A.
    Andreyeva, Tatyana
    Keegan, Sean
    Springer, John R.
    Schnute, Mark E.
    Dunussi-Joannopoulos, Kyri
    Nickerson-Nutter, Cheryl L.
    Rankin, Andrew L.
    Ruzek, Melanie
    Douhan, John, III
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S689 - S689
  • [46] Inhibition of Bruton's tyrosine kinase as a novel therapeutic approach in multiple sclerosis
    Torke, Sebastian
    Weber, Martin S.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (10) : 1143 - 1150
  • [47] A mechanism for localized dynamics-driven activation in Bruton's tyrosine kinase
    Qiu, Simei
    Liu, Yunfeng
    Li, Quhuan
    ROYAL SOCIETY OPEN SCIENCE, 2021, 8 (08):
  • [48] Involvement of Ras in Bruton's tyrosine kinase-mediated JNK activation
    Deng, JB
    Kawakami, Y
    Hartman, SE
    Satoh, T
    Kawakami, T
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) : 16787 - 16791
  • [49] Autoinhibition of Bruton's tyrosine kinase (Btk) and activation by soluble inositol hexakisphosphate
    Wang, Qi
    Vogan, Erik M.
    Nocka, Laura M.
    Rosen, Connor E.
    Zorn, Julie A.
    Harrison, Stephen C.
    Kuriyan, John
    ELIFE, 2015, 4
  • [50] Bruton's tyrosine kinase is essential for human B cell tolerance
    Ng, YS
    Wardemann, H
    Chelnis, J
    Cunningham-Rundles, C
    Meffre, E
    JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (07): : 927 - 934
12345